Ambee Pharmaceuticals (DHA:AMBEEPHA) Buyback Yield %: 0.00 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT791.00
View Full Analysis

What is Ambee Pharmaceuticals Buyback Yield %?

Ambee Pharmaceuticals DHA:AMBEEPHA +2.51% 18 Buyback Yield % is 0.00 as of Jul. 15, 2026. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100. Among 290 Drug Manufacturers companies, Ambee Pharmaceuticals ranks worse than 344827.24% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Ambee Pharmaceuticals's current buyback yield was 0.00%.

Ambee Pharmaceuticals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Buyback Yield % Chart

Ambee Pharmaceuticals Annual Data
Trend
Buyback Yield %

Ambee Pharmaceuticals Semi-Annual Data
Buyback Yield %

DHA:AMBEEPHA vs IMNPQ: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ambee Pharmaceuticals Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's Buyback Yield % falls into.


DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Ambee Pharmaceuticals's Buyback Yield for the fiscal year that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- ( + ) /
=N/A%

Ambee Pharmaceuticals's annualized Buyback Yield for the quarter that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- ( + ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Buyback Yield % of 0.00 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambee Pharmaceuticals and its competitors. According to the industry distribution chart, Ambee Pharmaceuticals ranks #999999 out of 290 companies in the Drug Manufacturers industry.
Is Ambee Pharmaceuticals' Buyback Yield % too high?
Ambee Pharmaceuticals' current Buyback Yield % is 0.00. Based on the distribution chart, Ambee Pharmaceuticals ranks #999999 out of 290 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Buyback Yield % compare to IMNPQ?
According to the Drug Manufacturers industry distribution chart, Ambee Pharmaceuticals ranks #999999 out of 290 companies for Buyback Yield %. This places Ambee Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Buyback Yield % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT791.00
Price